1. Home
  2. TNET vs PTGX Comparison

TNET vs PTGX Comparison

Compare TNET & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$57.18

Market Cap

2.6B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$89.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
PTGX
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
5.4B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
TNET
PTGX
Price
$57.18
$89.29
Analyst Decision
Hold
Strong Buy
Analyst Count
4
9
Target Price
$63.33
$86.44
AVG Volume (30 Days)
337.7K
898.7K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
1.93%
N/A
EPS Growth
N/A
N/A
EPS
2.65
0.72
Revenue
$4,971,000,000.00
$209,217,000.00
Revenue This Year
$2.83
N/A
Revenue Next Year
$2.67
$296.47
P/E Ratio
$21.52
$124.48
Revenue Growth
N/A
N/A
52 Week Low
$54.22
$33.70
52 Week High
$97.02
$93.25

Technical Indicators

Market Signals
Indicator
TNET
PTGX
Relative Strength Index (RSI) 45.54 64.67
Support Level $57.11 $83.52
Resistance Level $59.13 $90.85
Average True Range (ATR) 1.46 2.63
MACD 0.39 -0.33
Stochastic Oscillator 57.86 83.62

Price Performance

Historical Comparison
TNET
PTGX

About TNET TriNet Group Inc.

Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: